Search
for
Sort by
Research 61–90 of 1000+
- Occipital donor area grading and profile in Indian population
- EXPERIENCE OF A PRIVATE HOSPITAL IN THE FEDERAL DISTRICT IN CRYOTHERAPY WITH A HYPOTHERMAL CAP FOR PATIENTS USING PACLITAXEL 80 MG/M² WEEKLY FOR 12 WEEKS
- Association of Benign Prostatic Hyperplasia with Male Pattern Baldness
- Alisertib is active as single agent in recurrent atypical teratoid rhabdoid tumors in 4 children
- Clinical Characterization and Treatment Response of Folliculitis Decalvans Lichen Planopilaris Phenotypic Spectrum: A Unicentre Retrospective Series of 31 Patients
- Differences in Demographic and Clinical Characteristics Among Subtypes of Female Pattern Hair Loss
- Using Skindex-29 Scale to Assess The Impact of Androgenetic/Patterned Hair Loss on Quality of Life of Patients in Pakistan
- Docetaxel and oxaliplatin in the second-line treatment of platinum-sensitive recurrent ovarian cancer: a phase II study
- Open-Label, Randomized, Multicenter, Phase III Study Comparing Oral Paclitaxel Plus Encequidar Versus Intravenous Paclitaxel in Patients With Metastatic Breast Cancer
- Estudio descriptivo sobre la pérdida de cabello de patrón femenino en una consulta dermatológica general
- The development and validation of the hair shedding visual scale for Asian women (HSVS‐A)
- Polycystic ovary syndrome and the differential diagnosis of hyperandrogenism
- Safety Profile of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Disproportionality Analysis of FDA Adverse Event Reporting System
- Weekly docetaxel in minimally pretreated cancer patients: A dose-escalation study focused on feasibility and cumulative toxicity of long-term administration
- Arterielles popliteales Entrapment Syndrom (PAES) — ein Fallbericht zur Differentialdiagnose der Claudicatio intermittens
- Cemotherapi Induce Alopecia Due Carboplatin-Paclitaxel Regiment
- Eribulin Effectiveness and Safety in Metastatic Triple-Negative Breast Cancer: A Narrative Review
- The Efficacy and Safety of Anlotinib Plus Etoposide with Cisplatin/Carboplatin in the First-Line Treatment of Lung Cancer: A Phase II Clinical Study
- Safety of Alopecia Treatments in Patients with Breast Cancer and High-Risk Women: A Review
- Novel Lead Generation through Hypothetical Pharmacophore Three-Dimensional Database Searching: Discovery of Isoflavonoids as Nonsteroidal Inhibitors of Rat 5α-Reductase
- Risk of Estrogen-Driven Malignancies in Females on 5-alpha Reductase Inhibitors
- platelet-rich plasma versus topical 5% minoxidil in the treatment of androgenetic alopecia: A comparative observational study.
- Comparative Study That Evaluates the Effectiveness of Intradermotherapy with 0.5% Minoxidil Versus Topical Application of 5% Monoxidil Solution in the Treatment of Androgenetic Alopecia
- Eficacia y seguridad del plasma rico en plaquetas intralesional comparado con minoxidil al 5% tópico en el tratamiento de la alopecia androgenética masculina con afectación en vértex
- Syphilitic Alopecia: A Report of 5 Cases and a Review of the Literature
- BEARD—A Potential Donor Site in Grade 6 and Grade 7 Alopecia: A Case Series
- Efficacy of Platelet-rich Plasma for Treating Androgenic Alopecia of Varying Grades
- Comparative Study of effectiveness of low dose Oral Minoxidil vs Topical Minoxidil (5%) in Male Androgenetic Alopecia.
- Is seborrhoeic dermatitis associated with a diffuse, low‐grade folliculitis and progressive cicatricial alopecia?
- La FDA aprueba Litfulo® (ritlecitinib) para el tratamiento de la alopecia areata grave en adolescentes y adultos